September 11, 2020

Boston Regional Healthcare Compliance Conference

Virtual, Eastern Daylight Time (EDT)

Registration closed
View all past conferences

Handouts

Overall Survey | CEU Application | Conference Brochure

Hot Revenue Cycle Compliance Topics

Steve Gillis Director, Compliance & Coding, Billing & Audit at Partners Healthcare
Daniel Esquibel Senior Manager, Risk and Financial Advisory, Deloitte

• Provides an overview of price transparency rules for hospitals, including definition of standard charges and requirements for machine-readable and customerfriendly files
• Highlights strategic considerations for health systems of the Transparency in Coverage rule for payers, including employers offering self-funded coverage
• Addresses interaction of price transparency regulatory initiative with other federal rulemaking activities
• Identify new billing compliance risk areas that should be evaluated based on industry changes and recent OIG and other government agency reports
• Discuss methods for evaluating and monitoring new billing compliance risk areas

Presentation
Evaluation

Covid-19 Compliance Panel Discussion Session I; Patient and Employee Privacy

Beth Gutoff (Facilitator) Chief Compliance & Privacy Officer Elliot Health System
Rick King, MSJ, CHC, CIPP/US Chief Compliance Officer UMass Memorial Medical Center
Todd Torres, Esq. Associate General Counsel UMass Memorial Health Care
Lawrence Vernaglia Partner, Foley and Lardner LLP

• This interactive panel discussion is the first of two sessions in which compliance professionals will share their experiences as it relates to the Covid-19 pandemic. This session will focus on the impact that Covid-19 had on both patient and employee privacy. The following are some key topics that will be discussed:
- Patient Privacy Considerations
- Employee Privacy Considerations
- Telehealth Privacy Considerations
• Submit your questions prior to the conference and the panel will include your question in the panel discussion. “Live” questions may also be submitted during the session.

Presentation
Evaluation

Covid-19 Compliance Panel Discussion Session II

Jim Bryant (Facilitator) Vice President & Chief Compliance Officer Brigham Health
Beth Gutoff Chief Compliance & Privacy Officer Elliot Health System
Rick King, MSJ, CHC, CIPP/US Chief Compliance Officer UMass Memorial Medical Center
Lawrence Vernaglia Partner, Foley and Lardner LLP

• Key compliance risks, e.g. HIPAA Privacy & Security, Telehealth, EMTALA, Alternate Care Sites, Federal and State grants - Impacts to compliance programs, e.g. changing roles and responsibilities, staffing and budget reductions, compliance workplans
- Post pandemic planning, e.g. pandemic-specific workplan

Presentation
Evaluation

Keeping it Fresh: Strategies for Individual Development for Compliance and Privacy Professionals

Danielle M. Fagan, MSW, LICSW President & CEO- Anytime Leadership Clinical Performance Solutions PartnerLifespan, Adjunct Faculty- Johnson & Wales University
Donna Schneider, RN, MBA, CPHQ, CPC-P, CHC, CPCO, CHPC Vice President, Corporate Compliance & Internal Audit, Lifespan Health System

We all feel the effects of being “too busy” and finding time to invest in our own development is often a challenge. At the same time, the landscape of our work is ever changing, requiring us to stay current.
• Strategies for successful professional development for Compliance & Privacy staff, with a focus on leading self
• Participants will be inspired to increase their investment in their personal talent development and thrive in the workforce
• We will explore the importance and impact of individual growth, self-management, and staying current while on your Compliance & Privacy career journey

Presentation
Evaluation

Government Enforcement Panel

Gregg Shapiro Chief, Affirmative Civil Enforcement Unit U.S. Attorney’s Office, District of Massachusetts
Amanda Strachan Chief, Health Care Fraud Unit, Criminal Division, U.S. Attorney’s Office District of Massachusetts
Michael Fee Partner, Health Care & Life Sciences Group Verrill Dana LLP

• Discussion of DOJ Criminal and Civil Enforcement Priorities
• Emerging criminal and civil enforcement trends
• Recent cases, settlement agreements, CIAs, and related issues • The role of data in criminal and civil healthcare fraud cases

Presentation
Handout 1
Handout 2
Handout 3
Evaluation

Reading the Tea Leaves: Projecting Change in the Healthcare Industry Relating to the 2020 Presidential Election

Mike Capuano Director of Public Affairs, Foley & Lardner LLP
Mike Crossen Partner, Foley & Lardner, LLP

• Key health policy issues on the platforms of each candidate
• Predictions for what changes hospitals and other providers could expect following January 2021 inauguration
• What should a compliance officer be thinking about for projecting out the next 18 months

No Presentation Available
Evaluation